Cargando…
Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore developed a strategy of screening and containment for SARS-Co...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903402/ https://www.ncbi.nlm.nih.gov/pubmed/33627114 http://dx.doi.org/10.1186/s13027-021-00356-5 |
_version_ | 1783654730163027968 |
---|---|
author | Kaddu-Mulindwa, Dominic Thurner, Lorenz Bewarder, Moritz Murawski, Niels Ahlgrimm, Manfred Pfuhl, Thorsten Gärtner, Barbara Smola, Sigrun Stilgenbauer, Stephan |
author_facet | Kaddu-Mulindwa, Dominic Thurner, Lorenz Bewarder, Moritz Murawski, Niels Ahlgrimm, Manfred Pfuhl, Thorsten Gärtner, Barbara Smola, Sigrun Stilgenbauer, Stephan |
author_sort | Kaddu-Mulindwa, Dominic |
collection | PubMed |
description | Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore developed a strategy of screening and containment for SARS-CoV-2 for hospitalized cancer patients. Our approach includes a temporary isolation in a so-called floating zone and testing strategy for screening of asymptomatic individuals by pooling of samples before RT-PCR amplification. Patients as far as health care professionals got tested twice a week. Nurses and physicians entered the floating zone with full body protection. Within 8 weeks we tested 418 individuals (professionals and patients) in total. Only 2 patients had COVID-19 without documented further transmission of SARS-CoV-2. We therefore think that our strategy might be a useful approach to protect inpatients with cancer at high risk for SARS-CoV-2 infection during this ongoing pandemic. |
format | Online Article Text |
id | pubmed-7903402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79034022021-02-24 Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls Kaddu-Mulindwa, Dominic Thurner, Lorenz Bewarder, Moritz Murawski, Niels Ahlgrimm, Manfred Pfuhl, Thorsten Gärtner, Barbara Smola, Sigrun Stilgenbauer, Stephan Infect Agent Cancer Letter to the Editor Due to the worldwide COVID-19 outbreak it is mandatory for health care workers to develop containment strategies. Recently published data showed, that cancer patients might have a higher risk for severe course of the disease. We therefore developed a strategy of screening and containment for SARS-CoV-2 for hospitalized cancer patients. Our approach includes a temporary isolation in a so-called floating zone and testing strategy for screening of asymptomatic individuals by pooling of samples before RT-PCR amplification. Patients as far as health care professionals got tested twice a week. Nurses and physicians entered the floating zone with full body protection. Within 8 weeks we tested 418 individuals (professionals and patients) in total. Only 2 patients had COVID-19 without documented further transmission of SARS-CoV-2. We therefore think that our strategy might be a useful approach to protect inpatients with cancer at high risk for SARS-CoV-2 infection during this ongoing pandemic. BioMed Central 2021-02-24 /pmc/articles/PMC7903402/ /pubmed/33627114 http://dx.doi.org/10.1186/s13027-021-00356-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Kaddu-Mulindwa, Dominic Thurner, Lorenz Bewarder, Moritz Murawski, Niels Ahlgrimm, Manfred Pfuhl, Thorsten Gärtner, Barbara Smola, Sigrun Stilgenbauer, Stephan Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls |
title | Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls |
title_full | Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls |
title_fullStr | Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls |
title_full_unstemmed | Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls |
title_short | Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls |
title_sort | protection strategy against outbreak of covid-19 at a tertiary hematology-oncology: strengths and pitfalls |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903402/ https://www.ncbi.nlm.nih.gov/pubmed/33627114 http://dx.doi.org/10.1186/s13027-021-00356-5 |
work_keys_str_mv | AT kaddumulindwadominic protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls AT thurnerlorenz protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls AT bewardermoritz protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls AT murawskiniels protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls AT ahlgrimmmanfred protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls AT pfuhlthorsten protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls AT gartnerbarbara protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls AT smolasigrun protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls AT stilgenbauerstephan protectionstrategyagainstoutbreakofcovid19atatertiaryhematologyoncologystrengthsandpitfalls |